Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19

NCT04412785 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04412785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04412785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2020
Completion date
October 25, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19